Advanced search
Publication Cover
Therapeutic Delivery Volume 3, 2012 - Issue 10
Submit an article Journal homepage
225
Views
0
CrossRef citations to date
0
Altmetric
Review

Recent Advances in the Rational Design of silica-based Nanoparticles for Gene Therapy

Yuting Niua Australian Institute for Bioengineering & Nanotechnology The University of Queensland BrisbaneQLD4072Australia
,
Amirali Popata Australian Institute for Bioengineering & Nanotechnology The University of Queensland BrisbaneQLD4072Australia
,
Meihua Yua Australian Institute for Bioengineering & Nanotechnology The University of Queensland BrisbaneQLD4072Australia
,
Surajit Karmakara Australian Institute for Bioengineering & Nanotechnology The University of Queensland BrisbaneQLD4072Australia
,
Wenyi Gua Australian Institute for Bioengineering & Nanotechnology The University of Queensland BrisbaneQLD4072Australia
&
Chengzhong Yub Australian Institute for Bioengineering & Nanotechnology The University of Queensland [email protected]
Pages 1217-1237 | Published online: 23 Oct 2012

References

  • Anderson WF . Human gene-therapy. Science256(5058), 808–813 (1992).
  • Sokolova V , EppleM. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew. Chem. Int. Ed.47(8), 1382–1395 (2008).
  • Dufes C , UchegbuIF, SchatzleinAG. Dendrimers in gene delivery. Adv. Drug Deliv. Rev.57(15), 2177–2202 (2005).
  • Slowing II , Vivero-EscotoJL, WuCW, LinVSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev.60(11), 1278–1288 (2008).
  • Mao CQ , DuJZ, SunTMet al. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials 32(11), 3124–3133 (2011).
  • Arnold JD , MountainDJH, FreemanMBet al. Establishing Polymeric transfection as a non-viral, non-toxic method for gene therapy in the prevention of vascular disease. J. Vasc. Surg. 54(6), 1862–1862 (2011).
  • Sedighiani F , NikolS. Gene therapy in vascular disease. Surgeon9(6), 326–335 (2011).
  • Tuo J , Pang J-J, Cao X et al. AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2−/−/Cx3cr1−/− mice. Neurobiol. Aging33(2), 433, e1–e10 (2012).
  • Lieberman JR , DaluiskiA, StevensonSet al. The effect of regional gene therapy with bone morphogenetic protein-2- producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. A 81(7), 905–917 (1999).
  • Wang Y , GraingerDW. RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv. Drug Deliv. Rev.64(12), 1341–1357 (2012).
  • Morgan RA , DudleyME, WunderlichJRet al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314(5796), 126–129 (2006).
  • Gaspar HB , BjorkegrenE, ParsleyKet al. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 14(4), 505–513 (2006).
  • Raper SE , ChirmuleN, LeeFSet al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80(1–2), 148–158 (2003).
  • Hacein-Bey-Abina S , Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science302(5644), 415–419 (2003).
  • Fukumori Y , IchikawaH. Nanoparticles for cancer therapy and diagnosis. Adv. Drug Deliv. Rev.17(1), 1–28 (2006).
  • Kofron MD , LaurencinCT. Bone tissue engineering by gene delivery. Adv. Drug Deliv. Rev.58(4), 555–576 (2006).
  • Cuomo F , CeglieA, LopezF. Specific interactions between nucleolipid doped liposomes and DNA allow a more efficient polynucleotide condensation. J. Coll. Interface Sci.365(1), 184–190 (2012).
  • Kamiya H , FujimuraY, MatsuokaI, HarashimaH. Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem. Biophys. Res. Commun.298(4), 591–597 (2002).
  • Zhou X , HuangL. Targeted delivery of DNA by liposomes and polymers. J. Control. Release19(1–3), 269–274 (1992).
  • Wang ZJ , QianL, WangXL, YangF, YangXR. Construction of hollow DNA/PLL microcapsule as a dual carrier for controlled delivery of DNA and drug. Coll. Surf. A Physicochem. Eng. Asp.326(1–2), 29–36 (2008).
  • Moret I , Esteban Peris J, Guillem VM et al. Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum. J. Control. Release76(1–2), 169–181 (2001).
  • Navarro G , Tros De Ilarduya C. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomed. Nanotechnol. Biol. Med.5(3), 287–297 (2009).
  • Xiong X -B, Uludağ H, Lavasanifar A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials30(2), 242–253 (2009).
  • Ye SF , TianMM, WangTXet al. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. Nanomedicine 8(6), 833–841 (2011).
  • Adler AF , LeongKW. Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today5(6), 553–569 (2010).
  • Mintzer MA , SimanekEE. Nonviral vectors for gene delivery. Chem. Rev.109(2), 259–302 (2009).
  • Murthy SK . Nanoparticles in modern medicine: state of the art and future challenges. Int. J. Nanomed.2(2), 129–141 (2007).
  • Maiorano G , SabellaS, SorceBet al. Effects of cell culture media on the dynamic formation of protein–nanoparticle complexes and influence on the cellular response. ACS Nano 4(12), 7481–7491 (2010).
  • Osaki F , KanamoriT, SandoS, SeraT, AoyamaY. A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J. Am. Chem. Soc.126(21), 6520–6521 (2004).
  • Zhu Y , MengW, GaoH, HanagataN. hollow mesoporous silica/poly(L-lysine) particles for codelivery of drug and gene with enzyme-triggered release property. J. Phys. Chem. C115(28), 13630–13636 (2011).
  • Hartono SB , GuWY, KleitzFet al. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano 6(3), 2104–2117 (2012).
  • Lee H , SungD, VeerapandianM, YunK, SeoSW. PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery. Analyt. Bioanalyt. Chem.400(2), 535–545 (2011).
  • Zhu J , TangJW, ZhaoLZ, ZhouXF, WangYH, YuCZ. Ultrasmall, well-dispersed, hollow siliceous spheres with enhanced endocytosis properties. Small6(2), 276–282 (2010).
  • Xia TA , KovochichM, LiongMet al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3(10), 3273–3286 (2009).
  • Lin YS , HaynesCL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc.132(13), 4834–4842 (2010).
  • Zhu Y , FangY, BorchardtL, KaskelS. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microporous Mesoporous Mater.141(1–3), 199–206 (2011).
  • García-Calzón JA , Díaz-GarcíaME. Synthesis and analytical potential of silica nanotubes. Trends Analyt. Chem.35, 27–38 (2012).
  • Ashley CE , CarnesEC, PhillipsGKet al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers Nat. Mater. 10(6), 476–476 (2011).
  • Pedram EO , HinesAL. Pure vapor adsorption of water on mobil sorbead-R silica-gel. J. Chem. Eng. Data28(1), 11–14 (1983).
  • Ryoo R . Porous materials A tricontinuous mesoporous system. Nat. Chem.1(2), 105–106 (2009).
  • Zhao DY , FengJL, HuoQSet al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279(5350), 548–552 (1998).
  • Kresge CT , LeonowiczME, RothWJ, VartuliJC, BeckJS. Ordered mesoporous molecular-sieves synthesized by a liquid-crystal template mechanism. Nature359(6397), 710–712 (1992).
  • Stober W , FinkA, BohnE. Controlled growth of monodisperse silica spheres in micron size range. J. Coll. Interface Sci.26(1), 62–69 (1968).
  • He XX , WangKM, TanWHet al. Bioconjugated nanoparticles for DNA protection from cleavage. J. Am. Chem. Soc. 125(24), 7168–7169 (2003).
  • Slowing II , Vivero-EscotoJL, Wu C-W, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev.60(11), 1278–1288 (2008).
  • Xie J , LeeS, ChenX. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev.62(11), 1064–1079 (2010).
  • Dolatabadi JEN , De La Guardia M. Applications of diatoms and silica nanotechnology in biosensing, drug and gene delivery, and formation of complex metal nanostructures. Trends Analyt. Chem.30(9), 1538–1548 (2011).
  • Popat A , HartonoSB, StahrF, LiuJ, QiaoSZ, LuGQ. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale3(7), 2801–2818 (2011).
  • Popat A , LiuJ, LuGQ, QiaoSZ. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J. Mater. Chem.22(22), 11173–11178 (2012).
  • Livingston DM . Inheritance of the 2 micrometer m DNA plasmid from Saccharomyces. Genetics86(1), 73–84 (1977).
  • Shi FS , RakhmilevichAL, HeiseCPet al. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol. Cancer Ther. 1(11), 949–957 (2002).
  • Vivero-Escoto JL , SlowingII, LinVSY. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials31(6), 1325–1333 (2010).
  • Jung MR , ShimIK, KimESet al. Controlled release of cell-permeable gene complex from poly(L-lactide) scaffold for enhanced stem cell tissue engineering. J. Control. Release 152(2), 294–302 (2011).
  • Anderson RJ , SchneiderJ. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine25(Suppl. 2), B24–B34 (2007).
  • Suwalski A , DabboueH, DelalandeAet al. Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles. Biomaterials 31(19), 5237–5245 (2010).
  • Darquet AM , CameronB, WilsP, SchermanD, CrouzetJ. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther.4(12), 1341–1349 (1997).
  • Park JH , LeeM, KimSW. Non-viral adiponectin gene therapy into obese 2 type diabetic mice ameliorates insulin resistance. J. Control. Release114(1), 118–125 (2006).
  • Van Gaal EVB , OostingRS, HenninkWE, CrommelinDJA, MastrobattistaE. Junk DNA enhances pEI-based non-viral gene delivery. Int. J. Pharm.390(1), 76–83 (2010).
  • Fedor MJ . Structure and function of the hairpin ribozyme. J. Mol. Biol.297(2), 269–291 (2000).
  • Scott WG , FinchJT, KlugA. The crystal structure of an AII-RNAhammerhead ribozyme: a proposed mechanism for RNA catalytic cleavage. Cell81(7), 991–1002 (1995).
  • Pley HW , FlahertyKM, MckayDB. Three-dimensional structure of a hammerhead ribozyme. Nature372(6501), 68–74 (1994).
  • Kolniak TA , SullivanJM. Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents. Exp. Eye Res.92(5), 328–337 (2011).
  • Ozaki I , ZernMA, LiuS, WeiDL, PomerantzRJ, DuanL. Ribozyme-mediated specific gene replacement of the α1-antitrypsin gene in human hepatoma cells. J. Hepatol.31(1), 53–60 (1999).
  • Uhlmann E , PeymanA. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev.90(4), 543–584 (1990).
  • Stein C , ChengY. Antisense oligonucleotides as therapeutic agents – is the bullet really magical? Science261(5124), 1004–1012 (1993).
  • Su W -Y, Xiong H, Fang J-Y. Natural antisense transcripts regulate gene expression in an epigenetic manner. Biochem. Biophys. Res. Commun.396(2), 177–181 (2010).
  • Hamada K , ShirakawaT, GotohA, RothJA, FollenM. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Gynecol. Oncol.103(3), 820–830 (2006).
  • Bock LC , GriffinLC, LathamJA, VermaasEH, TooleJJ. Selection of single-stranded-DNA molecules that bind and inhibit human thrombin. Nature355(6360), 564–566 (1992).
  • Huizenga DE , SzostakJW. A DNA Aptamer that binds adenosine and ATP. Biochemistry34(2), 656–665 (1995).
  • Guo PX , CobanO, SneadNMet al. Engineering RNA for targeted siRNA delivery and medical application. Adv. Drug Deliv. Rev. 62(6), 650–666 (2010).
  • Hermann T , PatelDJ. Biochemistry – adaptive recognition by nucleic acid aptamers. Science287(5454), 820–825 (2000).
  • Nimjee SM , RusconiCP, SullengerBA. Aptamers: an emerging class of therapeutics. Annu. Rev. Med.56, 555–583 (2005).
  • Farokhzad OC , ChengJJ, TeplyBAet al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl Acad. Sci. USA 103(16), 6315–6320 (2006).
  • Zhang S , ZhaoY, ZhiD, ZhangS. Non-viral vectors for the mediation of RNAi. Bioorg. Chem.40, 10–18 (2012).
  • Hartono SB , GuW, KleitzFet al. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano 6(3), 2104–2117 (2012).
  • Fire A , XuSQ, MontgomeryMK, KostasSA, DriverSE, MelloCC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature391(6669), 806–811 (1998).
  • Mao C -Q, Du J-Z, Sun T-M et al. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials32(11), 3124–3133 (2011).
  • Kim JK , ChoiKJ, LeeM, JoMH, KimS. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials33(1), 207–217 (2012).
  • Rando TA . Oligonucleotide-mediated gene therapy for muscular dystrophies. Neuromusc. Disord.12, S55–S60 (2002).
  • Graham IR , DicksonG. Gene repair and mutagenesis mediated by chimeric RNA-DNA oligonucleotides: chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs). Biochim. Biophys. Acta1587(1), 1–6 (2002).
  • Li Z -H, Liu D-P, Yin W-X, Guo Z-C, Liang C-C. Targeted correction of the point mutations of β-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: potential for β-thalassemia gene therapy. Blood Cell. Mol. Dis.27(2), 530–538 (2001).
  • Ferreira GNM , MonteiroGA, PrazeresDMF, CabralJMS. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol.18(9), 380–388 (2000).
  • Minigo G , ScholzenA, TangCKet al. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy. Vaccine 25(7), 1316–1327 (2007).
  • Veiseh O , KievitFM, MokHet al. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 32(24), 5717–5725 (2011).
  • Burnett JC , RossiJJ. RNA-based therapeutics: current progress and future prospects. Chem. Biol.19(1), 60–71 (2012).
  • Zuker M . On Finding all suboptimal foldings of an RNA Molecule. Science244(4900), 48–52 (1989).
  • Correll CC , FreebornB, MoorePB, SteitzTA. Metals, motifs, and recognition in the crystal structure of a 5S rRNA domain. Cell91(5), 705–712 (1997).
  • Pleij CWA , BoschL. RNA pseudoknots – structure, detection, and prediction. Methods Enzymol.180, 289–303 (1989).
  • Jaeger JA , SantaluciaJ, TinocoI. Determination of RNA structure and thermodynamics. Annu. Rev. Biochem.62, 255–287 (1993).
  • Kaneko H , SuzukiH, AbeT, Miyano-KurosakiN, TakakuH. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Biochem. Biophy. Res. Commun.349(4), 1220–1227 (2006).
  • Zhu SG , XiangJJ, LiXLet al. Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol. Appl. Biochem. 39, 179–187 (2004).
  • Barnor JS , Miyano-KurosakiN, YamaguchiKet al. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells. Biochem. Biophys. Res. Commun. 320(2), 544–550 (2004).
  • Que-Gewirth NS , SullengerBA. Gene therapy progress and prospects: RNA aptamers. Gene Ther.14(4), 283–291 (2007).
  • Martell RE , NevinsJR, SullengerBA. Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol. Ther.6(1), 30–34 (2002).
  • Ishizaki J , NevinsJR, SullengerBA. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med.2(12), 1386–1389 (1996).
  • Nana-Sinkam SP , CroceCM. MicroRNAs as therapeutic targets in cancer. Transl. Res.157(4), 216–225 (2011).
  • Ashley CE , CarnesEC, EplerKEet al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. ACS Nano 6(3), 2174–2188 (2012).
  • Tagalakis AD , OwenJS, SimonsJP. Lack of RNA–DNA oligonucleotide (chimeraplast) mutagenic activity in mouse embryos. Mol. Reprod. Develop.71(2), 140–144 (2005).
  • Xiang S , TongH, ShiQet al. Uptake mechanisms of non-viral gene delivery. J. Control. Release 158(3), 371–378 (2012).
  • Van Der Aa MA , HuthUS, HafeleSYet al. Cellular uptake of cationic polymer–DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm. Res. 24(8), 1590–1598 (2007).
  • Vibin M , VinayakanR, JohnA, RejiyaCS, RajiV, AbrahamA. Cellular uptake and subcellular localization of highly luminescent silica-coated CdSe quantum dots – in vitro and in vivo. J. Coll. Interface Sci.357(2), 366–371 (2011).
  • Shen SD , GuT, MaoDSet al. Synthesis of nonspherical mesoporous silica ellipsoids with tunable aspect ratios for magnetic assisted assembly and gene delivery. Chem. Mater. 24(1), 230–235 (2012).
  • Park IY , KimIY, YooMK, ChoiYJ, ChoMH, ChoCS. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int. J. Pharm.359(1–2), 280–287 (2008).
  • Slowing I , TrewynBG, LinVSY. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticleson the endocytosis by human cancer cells. J. Am. Chem. Soc.128(46), 14792–14793 (2006).
  • Chung TH , WuSH, YaoMet al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19), 2959–2966 (2007).
  • Slowing II , WuCW, Vivero-EscotoJL, LinVSY. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small5(1), 57–62 (2009).
  • Xu Z , WangSL, GaoHW. Effects of nano-sized silicon dioxide on the structures and activities of three functional proteins. J. Hazard. Mater.180(1–3), 375–383 (2010).
  • Shi J , HedbergY, LundinM, Odnevall Wallinder I, Karlsson HL, Möller L. Hemolytic properties of synthetic nano- and porous silica particles: the effect of surface properties and the protection by the plasma corona. Acta Biomater.8(9), 3478–3490 (2012).
  • Yiu HHP , McbainSC, Lethbridge ZaD, Lees MR, Dobson J. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. J. Biomed. Mater. Res. A92A(1), 386–392 (2010).
  • Zhang X , MaGH, SuZG, Benkirane-JesselN. Novel poly(L-lysine) particles for gene delivery. J. Control. Release152, E182–E184 (2011).
  • Miyata K , GoudaN, TakemotoHet al. Enhanced transfection with silica-coated polyplexes loading plasmid DNA. Biomaterials 31(17), 4764–4770 (2010).
  • Khalil IA , KogureK, FutakiSet al. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther. 14(8), 682–689 (2007).
  • He QJ , ZhangJM, ShiJLet al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31(6), 1085–1092 (2010).
  • Radu DR , LaiCY, JeftinijaK, RoweEW, JeftinijaS, LinVSY. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc.126(41), 13216–13217 (2004).
  • Zeng P , XuY, ZengCH, RenH, PengML. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int. J. Pharm.415(1–2), 259–266 (2011).
  • Angelopoulou A , EfthimiadouEK, KordasG. Dextran modified pH sensitive silica hydro-xerogels as promising drug delivery scaffolds. Mater. Lett.74, 50–53 (2012).
  • Kunzmann A , AnderssonB, VogtCet al. Efficient internalization of silica-coated iron oxide nanoparticl es of different sizes by primary human macrophages and dendritic cells. Toxicol. Appl. Pharm. 253(2), 81–93 (2011).
  • Chen AM , ZhangM, WeiDGet al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5(23), 2673–2677 (2009).
  • Meng HA , LiongM, XiaTAet al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4(8), 4539–4550 (2010).
  • Cermenati G , TerraccianoI, CastelliIet al. The CPP Tat enhances eGFP cell internalization and transepithelial transport by the larval midgut of bombyx mori (lepidoptera, bombycidae). J. Insect Physiol. 57(12), 1689–1697 (2011).
  • Fonseca SB , PereiraMP, KelleySO. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev.61(11), 953–964 (2009).
  • Gao CB , Izquierdo-BarbaI, NakaseIet al. Mesostructured silica based delivery system for a drug with a peptide as a cell-penetrating vector. Microporous Mesoporous Mater. 122(1–3), 201–207 (2009).
  • Ziegler A , NerviP, DurrenbergerM, SeeligJ. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry44(1), 138–148 (2005).
  • Mao Z , WanL, HuL, MaL, GaoC. Tat peptide mediated cellular uptake of SiO2 submicron particles. Coll. Surf. B Biointerfaces75(2), 432–440 (2010).
  • Moore NM , SheppardCL, BarbourTR, Sakiyama-ElbertSE. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J. Gene Med.10(10), 1134–1149 (2008).
  • Oliveira S , Van Rooy I, Kranenburg O, Storm G, Schiffelers RM. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm.331(2), 211–214 (2007).
  • Sadeghian F , HosseinkhaniS, AlizadehA, HatefiA. Design, engineering and preparation of a multi-domain fusion vector for gene delivery. Int. J. Pharma427(2), 393–399 (2012).
  • Varkouhi AK , ScholteM, StormG, HaismaHJ. Endosomal escape pathways for delivery of biologicals. J. Control. Release151(3), 220–228 (2011).
  • Canton I , BattagliaG. Endocytosis at the nanoscale. Chem. Soc. Rev.41(7), 2718–2739 (2012).
  • Sauer AM , SchlossbauerA, RuthardtN, CaudaV, BeinT, BrauchleC. Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging. Nano Lett.10(9), 3684–3691 (2010).
  • Chang JH , KimKJ, ShinYK. Sustained drug release on temperature-responsive polymer hybrid nanoporous silica composites. Bull. Korean Chem. Soc.25(8), 1257–1260 (2004).
  • Chen F , ZhuY. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range. Microporous Mesoporous Mater.150(0), 83–89 (2012).
  • Xu Y , QuF, WangY, LinH, WuX, JinY. Construction of a novel pH-sensitive drug release system from mesoporous silica tablets coated with Eudragit. Solid State Sci.13(3), 641–646 (2011).
  • van der Aa M a, Mastrobattista E, Oosting RS, Hennink WE, Koning GA, Crommelin DJA. The nuclear pore complex: The gateway to successful nonviral gene delivery. Pharm. Res.23(3), 447–459 (2006).
  • Pan L , HeQ, LiuJet al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 134(13), 5722–5725 (2012).
  • Zhang JX , SunW, BergmanLet al. Magnetic mesoporous silica nanospheres as DNA/drug carrier. Mater. Lett. 67(1), 379–382 (2012).
  • Liu J , WangB, HartonoSBet al. Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake. Biomaterials 33(3), 970–978 (2012).
  • Yiu HHP , McbainSC, Lethbridge ZaD, Lees MR, Dobson J. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. J. Biomed. Mater. Res. A92A(1), 386–392 (2010).
  • Medintz IL , UyedaHT, GoldmanER, MattoussiH. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater.4(6), 435–446 (2005).
  • Michalet X , PinaudFF, BentolilaLAet al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709), 538–544 (2005).
  • Wu C -S, Oo MKK, Cupps JM, Fan X. Robust silica-coated quantum dot–molecular beacon for highly sensitive DNA detection. Biosens. Bioelectron.26(9), 3870–3875 (2011).
  • Christen V , FentK. Silica nanoparticles and silver-doped silica nanoparticles induce endoplasmatic reticulum stress response and alter cytochrome P4501A activity. Chemosphere87(4), 423–434 (2012).
  • Liu SH , ZhangZH, WangYB, WangFK, HanMY. Surface-functionalized silica-coated gold nanoparticles and their bioapplications. Talanta67(3), 456–461 (2005).
  • Witasp E , KupferschmidtN, BengtssonLet al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol. Appl. Pharm. 239(3), 306–319 (2009).
  • Russo PA , CarrottMMLR, MouraoPAM, CarrottPJM. Tailoring the surface chemistry of mesocellular foams for protein adsorption. Coll. Surf. A Physicochem. Eng. Asp.386(1–3), 25–35 (2011).
  • Drescher D , Orts-GilG, LaubeGet al. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Analyt. Bioanalyt. Chem. 400(5), 1367–1373 (2011).
  • Kim J , KimHS, LeeNet al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. 47(44), 8438–8441 (2008).
  • Ogris M , BrunnerS, SchullerS, KircheisR, WagnerE. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Therapy6(4), 595–605 (1999).
  • Lu F , WuSH, HungY, MouCY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small5(12), 1408–1413 (2009).
  • Chithrani BD , GhazaniAA, ChanWCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett.6(4), 662–668 (2006).
  • Li Y , SunL, JinMHet al. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol. Vitro 25(7), 1343–1352 (2011).
  • Chono S , TaninoT, SekiT, MorimotoK. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J. Pharm. Pharmacol.59(1), 75–80 (2007).
  • Lai SK , HidaK, ManSTet al. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28(18), 2876–2884 (2007).
  • Jiang W , KimBYS, RutkaJT, ChanWCW. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol.3(3), 145–150 (2008).
  • Guo J , BourreL, SodenDM, O‘sullivanGC, O‘driscollC. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol. Adv.29(4), 402–417 (2011).
  • Rai P , MallidiS, ZhengXet al. Development and applications of photo-triggered theranostic agents. Adv. Drug Deliv. Rev. 62(11), 1094–1124 (2010).
  • Zhao YN , SunXX, ZhangGN, TrewynBG, SlowingII, LinVSY. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano5(2), 1366–1375 (2011).
  • Liu F , YuaP, WanJJet al. Periodic mesoporous organosilicas with controlled pore symmetries for peptides enrichment. J. Nanosci. Nanotechnol. 11(6), 5215–5222 (2011).
  • Huang L , KrukM. Synthesis of ultra-large-pore FDU-12 silica using ethylbenzene as micelle expander. J. Coll. Interface Sci.365(1), 137–142 (2012).
  • Wang HN , ZhouXF, YuMHet al. Supra-assembly of siliceous vesicles. J. Am. Chem. Soc. 128(50), 15992–15993 (2006).
  • Suteewong T , SaiH, CohenRet al. Highly aminated mesoporous silica nanoparticles with cubic pore structure. J. Am. Chem. Soc. 133(2), 172–175 (2011).
  • Huang XL , TengX, ChenD, TangFQ, HeJQ. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials31(3), 438–448 (2010).
  • Huang XL , LiLL, LiuTLet al. The shape Effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5(7), 5390–5399 (2011).
  • Jankiewicz BJ , JamiolaD, ChomaJ, JaroniecM. Silica-metal core-shell nanostructures. Adv. Coll. Interface Sci.170(1–2), 28–47 (2012).
  • Jo C , KimK, RyooR. Syntheses of high quality KIT-6 and SBA-15 mesoporous silicas using low-cost water glass, through rapid quenching of silicate structure in acidic solution. Microporous Mesoporous Mater.124(1–3), 45–51 (2009).
  • Liu S , LuL, YangZ, CoolP, VansantEF. Further investigations on the modified Stöber method for spherical MCM-41. Mater. Chem. Phys.97(2–3), 203–206 (2006).
  • Kruk M , HuiCM. Synthesis and characterization of large-pore FDU-12 silica. Microporous Mesoporous Mater.114(1–3), 64–73 (2008).
  • Fantini MCA , KanagussukoCF, ZiliotiGJM, MartinsTS. Synthesis and structure of cage-like mesoporous silica using different precursors. J. Alloys Compounds509, S357–S360 (2011).
  • Parambadath S , RanaVK, MoorthySet al. Periodic mesoporous organosilicas with co-existence of diurea and sulfanilamide as an effective drug delivery carrier. J. Solid State Chem. 184(5), 1208–1215 (2011).
  • Shin JH , ParkSS, SelvarajM, HaCS. Adsorption of amino acids on periodic mesoporous organosilicas. J. Porous Mater.19(1), 29–35 (2012).
  • He QJ , ShiJL. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem.21(16), 5845–5855 (2011).
  • Park DH , NishiyamaN, EgashiraY, UeyamaK. Separation of organic/water mixtures with silylated MCM-48 silica membranes. Microporous and Mesoporous Materials66(1), 69–76 (2003).
  • Fenelonov VB , RomannikovVN, DerevyankinAL. Mesopore size and surface area calculations for hexagonal mesophases (types MCM41, FSM-16, etc.) using low-angle XRD and adsorption data. Microporous Mesoporous Mater.28(1), 57–72 (1999).
  • Bhattarai SR , MuthuswamyE, WaniAet al. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharm. Res. 27(12), 2556–2568 (2010).
  • Deng Z , ZhenZ, HuX, WuS, XuZ, ChuPK. Hollow chitosan–silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials32(21), 4976–4986 (2011).
  • Na H -K, Kim M-H, Park K et al. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. Small8(11), 1752–1761 (2012).
  • Kim MH , NaHK, KimYKet al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano 5(5), 3568–3576 (2011).
  • Lee HI , KimJH, StuckyGD, ShiYF, PakC, KimJM. Morphology-selective synthesis of mesoporous SBA-15 particles over micrometer, submicrometer and nanometer scales. J. Mater. Chem.20(39), 8483–8487 (2010).
  • Sun J , ZhangH, TianRet al. Ultrafast enzyme immobilization over large-pore nanoscale mesoporous silica particles. Chem. Commun. (12), 1322–1324 (2006).
  • Ji X , LeeKT, MonjauzeM, NazarLF. Strategic synthesis of SBA-15 nanorods. Chem. Commun. (36), 4288–4290 (2008).
  • Wagner CS , ShehataS, HenzlerK, YuanJY, WittemannA. Towards nanoscale composite particles of dual complexity. J. Coll. Interface Sci.355(1), 115–123 (2011).
  • Chen CC , LiuYC, WuCH, YehCC, SuMT, WuYC. Preparation of fluorescent silica nanotubes and their application in gene delivery. Adv. Mater.17(4), 404–407 (2005).
  • Bhushan B , JungYC. Natural and biomimetic artificial surfaces for superhydrophobicity, self-cleaning, low adhesion, and drag reduction. Prog. Mater. Sci.56(1), 1–108 (2011).
  • Nel AE , MadlerL, VelegolDet al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543–557 (2009).
  • Liu XM , HeJH. Hierarchically structured superhydrophilic coatings fabricated by self-assembling raspberry-like silica nanospheres. J. Coll. Interface Sci.314(1), 341–345 (2007).
  • Trewyn BG , NiewegJA, ZhaoY, LinVSY. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane, penetration. Chem. Eng. J.137(1), 23–29 (2008).
  • Parker AL , EckleyL, SinghS, PreeceJA, CollinsL, FabreJW. (LYS)16-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells. Biochim. Biophys. Acta1770(9), 1331–1337 (2007).
  • Lee SH , KimSH, ParkTG. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem. Biophys. Res. Commun.357(2), 511–516 (2007).
  • Pichon C , GonçalvesC, MidouxP. Histidine-rich peptides and polymers for nucleic acids delivery. Adv. Drug Deliv. Rev.53(1), 75–94 (2001).
  • Bardi G , MalvindiMA, GherardiniLet al. The biocompatibility of amino functionalized CdSe/ZnS quantum-dot-Doped SiO2 nanoparticles with primary neural cells and their gene carrying performance. Biomaterials 31(25), 6555–6566 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.